Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Bristol-Myers Squibb Company
Current Parent Company: Bristol-Myers Squibb
Penalty: $2,100,000
Year: 2009
Date: March 31, 2009
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: consumer protection violation
Violation Description: Drug maker Bristol-Myers Squibb Company was fined $2.1 million for failing to inform the Federal Trade Commission of an agreement reached with Apotex, Inc. under which Apotex agreed not to launch its generic version of Plavix for several years, and Bristol-Myers stated that it would not compete with Apotex during the first 180 days after Apotex did market its new generic drug.
Level of Government: federal
Action Type: agency action
Agency: Federal Trade Commission
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New York
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.